Integrin-linked kinase (ILK): a "hot" therapeutic target.
Yoganathan TN, Costello P, Chen X, Jabali M, Yan J, Leung D, Zhang Z, Yee A, Dedhar S, Sanghera J.
Yoganathan TN, et al. Among authors: leung d.
Biochem Pharmacol. 2000 Oct 15;60(8):1115-9. doi: 10.1016/s0006-2952(00)00444-5.
Biochem Pharmacol. 2000.
PMID: 11007949
Review.